These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 8639894)
1. Evidence for a novel binding protein to urokinase-type plasminogen activator in platelet membranes. Jiang Y; Pannell R; Liu JN; Gurewich V Blood; 1996 Apr; 87(7):2775-81. PubMed ID: 8639894 [TBL] [Abstract][Full Text] [Related]
2. Regulation of the urokinase-type plasminogen activator receptor on vascular smooth muscle cells is under the control of thrombin and other mitogens. Reuning U; Bang NU Arterioscler Thromb; 1992 Oct; 12(10):1161-70. PubMed ID: 1327097 [TBL] [Abstract][Full Text] [Related]
3. Characterization of the binding of human tissue-type plasminogen activator to platelets. Vaughan DE; Mendelsohn ME; Declerck PJ; Van Houtte E; Collen D; Loscalzo J J Biol Chem; 1989 Sep; 264(27):15869-74. PubMed ID: 2550424 [TBL] [Abstract][Full Text] [Related]
4. Identification and characterization of human endothelial cell membrane binding sites for tissue plasminogen activator and urokinase. Hajjar KA; Hamel NM J Biol Chem; 1990 Feb; 265(5):2908-16. PubMed ID: 2154465 [TBL] [Abstract][Full Text] [Related]
5. Thrombin decreases the urokinase receptor and surface-localized fibrinolysis in cultured endothelial cells. Li XN; Varma VK; Parks JM; Benza RL; Koons JC; Grammer JR; Grenett H; Tabengwa EM; Booyse FM Arterioscler Thromb Vasc Biol; 1995 Mar; 15(3):410-9. PubMed ID: 7749851 [TBL] [Abstract][Full Text] [Related]
6. Thrombin stimulation of platelets induces plasminogen activation mediated by endogenous urokinase-type plasminogen activator. Lenich C; Liu JN; Gurewich V Blood; 1997 Nov; 90(9):3579-86. PubMed ID: 9345041 [TBL] [Abstract][Full Text] [Related]
7. Binding of human single chain urokinase to Chinese Hamster Ovary cells and cloning of hamster u-PAR. Fowler B; Mackman N; Parmer RJ; Miles LA Thromb Haemost; 1998 Jul; 80(1):148-54. PubMed ID: 9684801 [TBL] [Abstract][Full Text] [Related]
8. Specific binding of urinary-type plasminogen activator (u-PA) to vitronectin and its role in mediating u-PA-dependent adhesion of U937 cells. Moser TL; Enghild JJ; Pizzo SV; Stack MS Biochem J; 1995 May; 307 ( Pt 3)(Pt 3):867-73. PubMed ID: 7537960 [TBL] [Abstract][Full Text] [Related]
9. Analysis of the binding of pro-urokinase and urokinase-plasminogen activator inhibitor-1 complex to the low density lipoprotein receptor-related protein using a Fab fragment selected from a phage-displayed Fab library. Horn IR; Moestrup SK; van den Berg BM; Pannekoek H; Nielsen MS; van Zonneveld AJ J Biol Chem; 1995 May; 270(20):11770-5. PubMed ID: 7538122 [TBL] [Abstract][Full Text] [Related]
10. Identification and characterization of the murine cell surface receptor for the urokinase-type plasminogen activator. Solberg H; Løber D; Eriksen J; Ploug M; Rønne E; Behrendt N; Danø K; Høyer-Hansen G Eur J Biochem; 1992 Apr; 205(2):451-8. PubMed ID: 1374026 [TBL] [Abstract][Full Text] [Related]
11. Proteolytically active streptococcal pyrogenic exotoxin B cleaves monocytic cell urokinase receptor and releases an active fragment of the receptor from the cell surface. Wolf BB; Gibson CA; Kapur V; Hussaini IM; Musser JM; Gonias SL J Biol Chem; 1994 Dec; 269(48):30682-7. PubMed ID: 7982988 [TBL] [Abstract][Full Text] [Related]
12. Urokinase binding and receptor identification in cultured endothelial cells. Haddock RC; Spell ML; Baker CD; Grammer JR; Parks JM; Speidel M; Booyse FM J Biol Chem; 1991 Nov; 266(32):21466-73. PubMed ID: 1657968 [TBL] [Abstract][Full Text] [Related]
13. Platelets from patients with the Quebec platelet disorder contain and secrete abnormal amounts of urokinase-type plasminogen activator. Kahr WH; Zheng S; Sheth PM; Pai M; Cowie A; Bouchard M; Podor TJ; Rivard GE; Hayward CP Blood; 2001 Jul; 98(2):257-65. PubMed ID: 11435291 [TBL] [Abstract][Full Text] [Related]
14. Interaction of single-chain urokinase-type plasminogen activator with human endothelial cells. Barnathan ES; Kuo A; Rosenfeld L; Karikó K; Leski M; Robbiati F; Nolli ML; Henkin J; Cines DB J Biol Chem; 1990 Feb; 265(5):2865-72. PubMed ID: 2154462 [TBL] [Abstract][Full Text] [Related]
15. Urokinase binding and catabolism by Hep G2 cells is plasminogen activator inhibitor-1 dependent, analogous to interactions of tissue-type plasminogen activator with these cells. Grimsley PG; Normyle JF; Brandt RA; Joulianos G; Chesterman CN; Hogg PJ; Owensby DA Thromb Res; 1995 Aug; 79(4):353-61. PubMed ID: 7482438 [TBL] [Abstract][Full Text] [Related]
16. Characterization of the binding of urokinase-type plasminogen activator (u-PA) to plasminogen, to plasminogen-activator inhibitor-1 and to the u-PA receptor. Lijnen HR; De Cock F; Collen D Eur J Biochem; 1994 Sep; 224(2):567-74. PubMed ID: 7925373 [TBL] [Abstract][Full Text] [Related]
17. Characterization of the binding of plasminogen activators to plasma membranes from human liver. Nguyen G; Self SJ; Camani C; Kruithof EK Biochem J; 1992 Nov; 287 ( Pt 3)(Pt 3):911-5. PubMed ID: 1445249 [TBL] [Abstract][Full Text] [Related]
18. Effect of chemical conjugation of recombinant single-chain urokinase-type plasminogen activator with monoclonal antiplatelet antibodies on platelet aggregation and on plasma clot lysis in vitro and in vivo. Dewerchin M; Lijnen HR; Stassen JM; De Cock F; Quertermous T; Ginsberg MH; Plow EF; Collen D Blood; 1991 Aug; 78(4):1005-18. PubMed ID: 1831057 [TBL] [Abstract][Full Text] [Related]
20. Binding and activation of plasminogen on the platelet surface. Miles LA; Plow EF J Biol Chem; 1985 Apr; 260(7):4303-11. PubMed ID: 3920216 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]